Scientific article
English

Rivastigmine for HIV-associated neurocognitive disorders: a randomized crossover pilot study

Published in

Neurology, vol. 80, no. 6, p. 553-560

Publication date

2013

Abstract

To assess the efficacy and safety of rivastigmine for the treatment of HIV-associated neurocognitive disorders (HAND) in a cohort of long-lasting aviremic HIV+ patients.

Keywords

  • AIDS Dementia Complex/drug therapy
  • Cross-Over Studies
  • Double-Blind Method
  • Executive Function/drug effects
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neuroprotective Agents/therapeutic use
  • Neuropsychological Tests
  • Phenylcarbamates/therapeutic use
  • Pilot Projects

UNIGE research groups

Citation (ISO format)

SIMIONI, Samanta et al. Rivastigmine for HIV-associated neurocognitive disorders: a randomized crossover pilot study. In: Neurology, 2013, vol. 80, n° 6, p. 553–560. doi: 10.1212/WNL.0b013e3182815497

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

0028-3878
844views
1downloads

Technical informations

Creation

03/12/2013 15:42:00

First validation

03/12/2013 15:42:00

Update

14/03/2023 20:56:06

Status update

14/03/2023 20:56:06

Last indexation

30/10/2024 16:08:52
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated